Effect of homologous transfusions and the autologous blood recovery system in highly complex surgical patients

Authors

  • Jennifer Delgado Rivas Hospital "Alcívar", Guayaquil.
  • Patricio Echanique Hospital "Alcívar", Guayaquil.
  • Jorge Plaza Cepeda Hospital "Alcívar", Guayaquil.

Keywords:

autologous blood recovery system (cell saver), homologous blood, autologous blood, highly complex surgical interventions.

Abstract

Introduction: Autologous transfusion has three modalities: autologous transfusion with predeposit, preoperative hemodilution (normovolemic or hypervolemic), and the system for autologous blood recovery (cell saver), whether intraoperative or postoperative.
Objective: To show the effectiveness of the use of the autologous blood recovery system in highly complex surgical patients at Alcívar Hospital.
Method: Nonexperimental, retrospective study, of indirect observation and with correlational analysis. The sample consisted of 112 patients who underwent surgery for cardiovascular, orthopedic and traumatological conditions, chosen based on inclusion and exclusion criteria. The cell saver system was used in 56 patients and 56 patients used homologous blood transfusions.
Results: The cell saver system was beneficial in 93 % of patients; morbidity and mortality decreased, mainly in patients operated for any cardiovascular condition, while the cost-benefit ratio increased, due to the fact prioritization of economic resources. In traumatology and orthopedics, it was not so beneficial, since the amount of blood recovered fluctuated between 300 and 500 mL in conventional interventions, which motivated the use of blood products and increased the cost. In tumor resections and instrumentation of different spine segments, up to 800 mL of blood were recovered, which was significant. The complication rate was lower in patients who used the cell saver system (7 %), compared to patients who used homologous blood products (32 %). A shorter hospital stay was observed in the cell saver group (1-20 days), compared to those who used homologous blood products (over 10 days, while in 5 cases it was over 21 days).
Conclusions: The use of the autologous blood recovery system is an effective procedure to infuse blood products with greater safety.

Downloads

Download data is not yet available.

References

Barbolla L, Contreras E, Pujol M. Manual práctico de medicina transfusional. Madrid: FEHH; 2002. p. 243-9.

Organización Panamericana de la Salud. Estándares de Trabajo para Servicios de Sangre. 3ra. ed. 2012. Washington, D.C.: OPS; 2012. p. 87, 115-22.

INEC. Anuario de Estadísticas Hospitalarias: Egresos y Camas. Ecuador. [Internet] 2014. [Citado el 20 de agosto 2016]. Disponible en http://www.ecuadorencifras.gob.ec/

Plaza Cepeda J. Temas prácticos en anestesia y medicina perioperatoria. Edición. Guayaquil: Hospital Alcívar; 2003. p. 309-20.

Ysasi A, TrujilloM, Tuesta I, Llorens R, Herreros E. El recuperador celular (cell saver) en cirugía de revascularización coronaria sin circulación extracorpórea reduce necesidades transfusionales. Rev Esp Anestesiol Reanim. 2006;53:465-70.

Leal S, Muñoz M, Asuero M, Contreras E, García J, Llau V, et al. Documento "Sevilla" de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización. Rev Española. 2013;36(6):209-35.

Nalla BP, Freedman J, Hare GM, Mazer CD. Update on blood conservation for cardiac surgery. J Cardiothorac Vasc Anesth. 2012;26:117-33.

Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials. Anestesia & Analgesia. 2009;109:320-30.

García García E. Pautas transfusionales en el paciente quirúrgico. Rev Cubana Anestesiol Reanim. 2013;12(3):231-43.

Rollins KE, Trim NL, Luddington RJ, Colah S, Klein A, Besser MW, et al. Coagulopathy associated with massive cell salvage transfusion following aortic surgery. Perfusion. 2012;27: 30-3.

Owens R, Crawford C, Djurasovic M, Canan C, Burke L, Bratcher K, et al. Predictive factors for the use of autologous cell saver transfusion in lumbar spinal surgery. Spine Diagnostic. 2013;38 (4):217-22.

Almeida R, Leitáo L. The use of cell saver system in cardiac surgery with cardiopulmonary bypass. Rev Bras Cir Cardiovasc. 2013;28 (1):76-82.

Arrieta G. Intervenciones para conservar la sangre en cirugía cardíaca con circulación extracorpórea. Revista Mexicana. 2012;20(1):17-20.

Friedman R, Homering M, Holberg G, Berkowitz S. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. The Journal Of Bone and Joint Surgery. 2014;96(4):272-8.

Newman E, Steven T, Lewis J, Jennings J, Wellman S, Attarian D, et al. Impact of Perioperative Allogeneic and Autologous Blood Transfusion on Acute Wound Infection Following Total Knee and Total Hip Arthroplasty. The Journal Of Bone and Joint Surgery. 2015;96(4):279-84.

Rivera D, Pérez A. Técnicas de ahorro sanguíneo en cirugía. Rev Colomb Anestesiol. 2012;39(4):545-59.

Rui M, Almeida S, Leitão L. The use of cell saver system in cardiac surgery with cardiopulmonary bypass. Rev Bras Cir Cardiovasc. 2013;28(1):76-82.

Downloads

Published

2017-09-03

How to Cite

1.
Delgado Rivas J, Echanique P, Plaza Cepeda J. Effect of homologous transfusions and the autologous blood recovery system in highly complex surgical patients. Rev Cub Anest Rean [Internet]. 2017 Sep. 3 [cited 2025 Jun. 5];16(3). Available from: https://revanestesia.sld.cu/index.php/anestRean/article/view/129

Issue

Vol. 16 No. 3 (2017): september - december

Section

Original articles

License

Those authors who have publications with this journal accept the following terms:

      • They will retain their copyright and guarantee the journal the right of the first publication of their work.
      • All the content of the journal is under a license https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES
      • It is recommended to the author to insert their articles in recognized preprints serves and introduce their database in server crated to this end.